Study of Gallium Oxide Nanoparticles Conjugated with β-Cyclodextrin: An Application To Combat Cancer
Source abstract
Abstract
Bioactive nanomaterials, namely, gallium oxyhydroxide GaO(OH), also surface-conjugated GaO(OH) with a giant sugar molecule β-cyclodextrin (CD), have been prepared through a simple wet chemical route such that the same could be suitably used in biomedical diagnostics as well as therapeutic applications. Several physical methods were used for their characterization: powder X-ray diffraction pattern of GaO(OH) NPs for their grain size determination, optical spectroscopic absorption (UV-vis and FT-IR), and fluorescence properties of these NPs to ascertain surface conjugation and also their wide band-gap properties. Besides these, morphological properties of these NPs were studied by transmission electron microscopic (TEM) investigation, justifying the elemental constitution through energy dispersive X-ray analysis (EDX). Further, biological cellular uptake of these nanoparticles have been demonstrated on cancerous HeLa cells and reported with total fetal effect after 72 h, with CD templated GaO(OH) nanoparticles, a fact that has not been reported so far.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications · Magnesium Oxide Properties and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Saha Institute of Nuclear Physics, 1/AF Bidhannagar, Kolkata 700064, India
IISER-Pune, Dr. Homi Bhabha Road, Pashan, Pune 411008, India
IISER-Kolkata, Mohanpur 741246, West Bengal, India
References (47)
Show source-provided references
1. 10.1016/j.mattod.2015.07.00410.1016/j.mattod.2015.07.004 ↗
2. 10.1517/17425247.2010.50256010.1517/17425247.2010.502560 ↗
3. 10.1186/s12951-014-0059-z10.1186/s12951-014-0059-z ↗
4. 10.1126/science.111439710.1126/science.1114397 ↗
5. 10.1021/ja01288a03110.1021/ja01288a031 ↗
6. 10.1021/jp710545p10.1021/jp710545p ↗
7. 10.1021/jp037427n10.1021/jp037427n ↗
8. 10.1016/j.jinorgbio.2012.08.00510.1016/j.jinorgbio.2012.08.005 ↗
9. Bernstein L. R. · Pharmacol. Rev. · 1998 · 50 · 665
10. 10.1016/j.apradiso.2013.01.03910.1016/j.apradiso.2013.01.039 ↗
11. 10.1007/s10967-007-7256-210.1007/s10967-007-7256-2 ↗
12. 10.1021/jm500185810.1021/jm5001858 ↗
13. 10.2967/jnumed.107.04037810.2967/jnumed.107.040378 ↗
14. 10.1016/0047-0740(81)90033-410.1016/0047-0740(81)90033-4 ↗
15. 10.1155/MBD.2000.3310.1155/MBD.2000.33 ↗
16. Dudley H. C. · J. Pharmacol. Exp. Ther. · 1949 · 96 · 224
17. Nelson B. · J. Nucl. Med. · 1972 · 13 · 92
18. Vallabhajosula S. R. · J. Nucl. Med. · 1980 · 21 · 650
19. 10.1039/c2cs15294k10.1039/c2cs15294k ↗
20. 10.1186/1477-3155-12-510.1186/1477-3155-12-5 ↗
21. 10.1016/j.ijpharm.2012.06.05510.1016/j.ijpharm.2012.06.055 ↗
22. 10.1517/17425247.2.1.33510.1517/17425247.2.1.335 ↗
23. 10.1177/019262330731094510.1177/0192623307310945 ↗
24. Valk, P. E.; Bailey, D. L.; Townsend, D. W.; Maisey, M. N.Positron Emission Tomography: Basic Science and Clinical Practice;Springer-Verlag, Ltd.:London, 2003; p147.
25. 10.1021/jp047664610.1021/jp0476646 ↗
26. HeLa.https://en.wikipedia.org/wiki/HeLa.
27. 10.1093/jnci/82.13.111310.1093/jnci/82.13.1113 ↗
28. Cullity B. D. · 2001
29. 10.1021/cm034948e10.1021/cm034948e ↗
30. Kwak, S.Y.; Chung, J.W.U.S. Patent Application Publication US2010/0092376 A1, Apr 15, 2010.
31. 10.1186/1477-3155-10-2910.1186/1477-3155-10-29 ↗
32. Bellamy L.J. · 1959
33. Svehla G. · 1976
34. 10.1016/j.saa.2009.06.03210.1016/j.saa.2009.06.032 ↗
35. 10.1021/jz101228z10.1021/jz101228z ↗
36. 10.1039/DF959270000710.1039/DF9592700007 ↗
37. 10.1143/JJAP.38.388810.1143/JJAP.38.3888 ↗
38. Lakowicz J. R. · 199910.1007/978-1-4757-3061-6 ↗
39. Blell J. D. · EMBO Journal · 1982 · 1 · 35110.1002/j.1460-2075.1982.tb01173.x ↗
40. Lamb J. E. · J. Biol. Chem. · 1983 · 258 · 875110.1016/S0021-9258(18)32120-3 ↗
41. Allamneni K. P. · Proc. Am. Assoc Cancer Res. · 2004 · 45 · 230
42. 10.1021/nn300223w10.1021/nn300223w ↗
43. 10.1155/MBD.2000.3310.1155/MBD.2000.33 ↗
44. MTT Cell Proliferation Assay.http://www.atcc.org/~/media/DA5285A1F52C414E864C966FD78C9A79.ashx.
45. Chua M.-S. · Anticancer Res. · 2006 · 26 · 1739
46. Qian Z. M. · Pharmacol. Rev. · 2002 · 54 · 56110.1124/pr.54.4.561 ↗
47. Joseph T. P. · 2005